Drug Discovery

FDA Nodded Sunovion’s Latuda for Bipolar Depression in Pediatric Patients

On March 8, 2018, the U.S. Food and Drug Administration approved the expanded use of the anti-psychotic drug Latuda (also referred to as lurasidone HCI) for a new indication – to […]

Metformin — A “Wonder Drug” Beyond type 2 Diabetes

Metformin has proven to be a “magic drug” beyond its application in treating diabetes. Over the past 20 years, metformin has become the mainstay of type 2 diabetes treatment and […]

An overview of olaparib approved by FDA

Olaparib, also known as AZD-2281 or KU-59436, is a small molecule inhibitor of the nuclear enzyme poly (ADP-ribose) polymerase (PARP) with potential chemosensitizing, radiosensitizing, and antineoplastic activities. Olaparib selectively binds to […]

FDA Approved Semaglutide for Type 2 Diabetes

On Oct. 18, 2017, the Food and Drug Administration (FDA)’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has unanimously voted 16-0 to support the approval of Novo Nordisk’s semaglutide, a […]

Exatecan mesylate

Maintenance of DNA topology is critical for normal DNA replication, transcription and repair in eukaryotic cells. One family of enzymes, the topoisomerases, is essential for this process. Eukaryotic topoisomerase I […]

Neonicotinoid insecticides

The main control measures in cotton fields in China include chemical control, cultural control (e.g., intercropping with trap crops), physical control (e.g., light traps and sticky traps), and biological control […]

FDA Recently Approved Three Drugs to Treat Leukemia

FDA Recently Approved Three Drugs to Treat Leukemia

Acute myeloid leukemia (AML) is a rapidly progressing cancer that forms in the bone marrow and results in an increased number of white blood cells in the bloodstream. The National […]

FDA Approves Neratinib for Extended Adjuvant Treatment of Breast Cancer

On July 17, 2017, the U.S. Food and Drug Administration approved neratinib (Nerlynx, Puma Biotechnology, Inc.) for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer to […]

Antibody-drug conjugates

Antibody-drug conjugates

The concept of arming antibodies by conjugation to protein toxins dates back to 1970, and was followed a few years later by antibody conjugates with cytotoxic drugs. Antibody therapeutics have come of age […]

Effect of White, Red and Black Ginseng on Physicochemical Properties and Ginsenosides

Effect of White, Red and Black Ginseng on Physicochemical Properties and Ginsenosides

A systematic comparison of the ginsenosides and physicochemical properties of white ginseng (WG), red ginseng (RG) and black ginseng (BG) was performed. The purpose of the present study was to identify […]